• charter.png
    Charter

     

    The purpose of the Rosacea Research & Development Institute [RRDi] is to fund research and development for finding a cure for rosacea by establishing a Medical Advisory Committee [MAC] of the best available minds on rosacea and to publish the results of this endeavor to the public and professional groups. This MAC will provide the direction of the research. Research may also include studying various treatments for the control of rosacea in multi-center, double blind, placebo controlled clinical trial studies. The RRDi is commited to support patient advocacy for those suffering from rosacea. This organization is open to the public and membership is free and has been organized by rosaceans for rosaceans. This organization is a non-profit corporation registered in the State of Hawaii and 501 (c) (3) tax-exempt status approval has been obtained from the IRS effective June 7, 2004. The Articles of Incorporation, the Bylaws, and the Conflict of Interest Policy are available for the public.

     

    Membership is open to the public and is free. Rosaceans are specially invited to join. All who join become members of the corporation and for now this number is not limited but may be revised in the future by the institute.

    A rosacean is anyone who is diagnosed by a physician as having rosacea. All that is necessary to be designated a rosacean institute member is a statement from the member that a diagnosis of rosacea has been obtained from a physician.

    Non-rosaceans are permitted to join and should identify themselves as such upon demand from the institute. Non-rosaceans are those who have not obtained a diagnosis of rosacea by a physician.

    Any member of the institute may be removed from the membership at any time at the sole discretion of the institute. Rules of the institute are published and available to the public. Violation of the rules may be grounds for termination as a member of the institute. Membership in the institute is a privilege.

    Funding will provide a rosacea MAC of the best available minds on finding a cure for this disease. The selection of who is chosen to be in this MAC will be based on not only the qualifications of the individual but also from nominations by both rosacean and non rosaceans members of the institute.

    Sources of funding to the institute will be publicized including the name of the donor unless the donor requests anonymity. Expenses of the institute will be publicized down to the last cent, showing where all the spending went and for what purpose.

    The philosophy and spirit of this institute is that funding should predominately be used for research and development and not for the administration of the institute. Volunteers are an integral part of this spirit and we hope to include member rosaceans and non-rosaceans who are willing to help the purpose of the institute become a reality. We need your help to find a cure for rosacea, to research rosacea, to publish the findings of this research and provide a MAC of the best available minds on rosacea. The views and suggestions of rosaceans will be an integral part in directing the research on rosacea, in choosing the MAC and the directors of the institute. Members of the institute will have a voice in the decision making of the institute, although directors of the institute will make all final decisions.

    Members of the institute will not profit from the institute however the Medical Advisory Committee members or members may be compensated for services rendered to the institute.

    Members will elect a board of directors which will include:

    Director, Assistant Director, Secretary, Treasurer and other board members. The board of directors will decide all matters of the institute and will be volunteers.

    Funding on rosacea research by the RRDi will not be used on animal testing.

    Our Mission Statement may be read by clicking here.

    This charter may be revised from time to time by the institute when deemed appropriate at the sole discretion of the institute.



  • Posts

    • You may be able to save some money using the Mission Pharmacal Savings Card program for their product line. 
    • The following nine products are recommended by Cosmopolitan:  Aveeno Ultra-Calming Nourishing Night Cream

      La Roche-Posay Rosaliac AR Intense

      Cetaphil Redness Relieving Daily Facial Moisturizer

      First Aid Beauty Anti Redness Serum

      Skinceuticals Redness Neutralizer

      Elemis Daily Redness Solution

      Eucerin Sensitive Skin Redness Relief Soothing Night Creme Rhofade

      IT COSMETICS Your Skin But Better CC Cream Light
        9 Products You're Not Using to Calm Your Rosacea but Should, by CARLY CARDELLINO, Cosmopolitan
    • After a couple of pool visits, I noticed a rash forming on my arms and blotchy, red patches on my face. Like a responsible adult woman, I decided to see my family doctor who told me that the condition of my skin was “concerning” and “may have been caused by chlorine.” The doctor diagnosed it as “probably rosacea” and prescribed me an antibiotic compound cream which I have to slather on my face three times a day. Letter: The new pool gave me dry skin, a rash and probably rosacea, By Anita Rudakov. The Ubyssy
    • Related Articles TRPV4 Moves toward Center-Fold in Rosacea Pathogenesis. J Invest Dermatol. 2017 Apr;137(4):801-804 Authors: Chen Y, Moore CD, Zhang JY, Hall RP, MacLeod AS, Liedtke W Abstract
      Mascarenhas et al. report that TRPV4 expression is upregulated in mast cells in response to the proteolytic cathelicidin fragment LL37 in a murine rosacea model and that TRPV4 loss of function attenuates mast cell degranulation. These findings render TRPV4 a translational-medical target in rosacea. However, signaling mechanisms causing increased expression of TRPV4 await elucidation. Moreover, we ask whether TRPV4-mediated Ca(++)-influx evokes mast cell degranulation.
      PMID: 28340683 [PubMed - in process] {url} = URL to article
    • Related Articles Giant Rhinophyma: A Rare Case of Total Nasal Obstruction and Restitutio Ad Integrum. Aesthetic Plast Surg. 2017 Mar 24;: Authors: Wolter A, Scholz T, Liebau J Abstract
      Rhinophyma is considered the end stage in the development of rosacea, accompanied by hypertrophy of the sebaceous glands, which causes an enlargement of the nose. It is an uncommon condition that often results in both functional and cosmetic impairment. A large variety of surgical and nonsurgical treatments have been published to treat it. Closure is usually obtained by wound granulating in by secondary intention, skin grafting or local flaps. Rarely these lesions can attain a giant size and pose a challenge in surgical treatment. We present a 63-year-old male with the necessity for tracheostomy at the ICU due to total nasal obstruction and recurrent episodes of pneumonia caused by a huge giant rhinophyma, which had undergone extreme growth in the last five years. The tumor was removed under general anesthesia by decortication with an electrosurgical wire loop to recreate the aesthetic units of the nose preserving the alar cartilage as well as the pilosebaceous appendages. The wounds healed in by secondary intention with a very pleasant cosmetic and improved functional result. The relevant literature is discussed. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
      PMID: 28341953 [PubMed - as supplied by publisher] {url} = URL to article